April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The global market for oral iron supplements is growing rapidly and is expected to generate hundreds of millions of dollars in revenue by 2034. This rise is fueled by increasing demand and new trends emerging in various industries. The rising incidences of iron-deficiency anemia and the increasing awareness of nutritional balance drive the market. N...
April 21, 2026
Based on market forecasts, the global complementary and alternative medicine market, projected at USD 181.39 billion in 2024, is expected to reach USD 1734.78 billion by 2034, growing at a CAGR of 25.34% over the forecast period. The market is growing as more people seek natural and holistic health options. Concerns about the side effects of conven...
April 21, 2026
According to market projections, the viral sensitizers sector is expected to grow from USD 2.04 billion in 2024 to USD 8.02 billion by 2034, reflecting a CAGR of 14.63%. The viral sensitizers market is expanding due to rising viral diseases as well as increasing vaccine development. North America led the market due to the presence of advanced R&...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding due to the rising occurrence of non-small cell lung cancer as well as growing targeted treatment appr...
April 21, 2026
Market insights predict the global non-viral transfection reagents industry will increase from USD 1.85 billion in 2024 to USD 4.29 billion by 2034, achieving a CAGR of 8.73%. The non-viral transfection reagents market is growing because of the increasing application of these reagents in various healthcare sectors such as gene therapy, research, dr...
April 21, 2026
The development of better immunity against the growing variants of COVID-19 viruses promotes the growth of the next-gen COVID-19 vaccine market. North America is dominating the market due to the growing research on next-generation vaccines....
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing due to rising disease prevalence, improved diagnosis, and increasing demand for advanced targeted ther...
April 21, 2026
According to Towards Healthcare research, globally, an increasing number of epilepsy cases, which are demanding effective ASM, along with developments in pharmaceutical companies for novel drugs, are driving the market growth. Whereas, North America experienced dominance due to growing epilepsy prevalence and boosting activities in R&D. ...
April 21, 2026
The next-generation bispecific antibody market is expanding due to increasing diseases as well as rising autoimmune diseases treatment approaches. North America led the market due to the presence of well-developed industries....
April 21, 2026
Market insights predict, the Europe dermal filler industry is expected to grow from USD 1.84 billion in 2024 to USD 4.23 billion by 2034, driven by a CAGR of 8.84%. The Europe dermal filler market is growing due to rising focus on beauty standards....